A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment
NCT00393497
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Lymphedema
Interventions
DRUG:
bevacizumab
Sponsor
Indiana University